The global HIV drugs market by class of drugs (Multi-class combination products, Nucleoside reverse transcriptase inhibitors,Non-nucleoside reverse transcriptase inhibitors,Protease inhibitors,Fusion inhibitors,Entry inhibitors - CCR5 co-receptor antagonist and HIV integrase strand transfer inhibitors) 2015-2019 analysis and forecasts.
Pune, Maharastra -- (SBWIRE) -- 10/20/2015 -- Commenting on the Global HIV Drugs Market 2015-2019 report, an analyst said: "Strategic alliances formed between companies, in terms of licensing and collaboration, is a key market trend that is helping co-development and commercialization of drugs in different regions." The forecast global HIV drugs market to grow at a CAGR of 4.52% over the period 2014-2019.
According to the Global HIV Drugs Market 2015-2019 report, unmet medical needs in the market present significant growth opportunities for vendors.
Further, the Global HIV Drugs Market 2015-2019 report states that adverse effects such as hepatotoxicity, hyperglycemia, hyperlipidemia, lactic acidosis, lipodystrophy, osteonecrosis, osteopenia, osteoporosis, and skin rash presents a significant challenge to this market.
The following companies are the key players in the Global HIV Drugs Market: Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, and Merck.
Other Prominent Vendors in the market are: AbbVie, AstraZeneca, Boehringer Ingelheim, Cipla, Daiichi Sankyo, Emcure, F. Hoffmann-La Roche, Hetero Drugs, Mylan, Pfizer, Shionogi, and Teva Pharmaceutical Industries.
This report covers the present scenario and the growth prospects of the global HIV drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic and branded drugs and the expected launch of drug candidates used in the treatment of HIV infection.
The report analysis the market based on the class of drugs.
Purchase a Copy of Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=424250.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
The report, Global HIV Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire For DISCOUNT